Você procurou por: tranylcypromine (Inglês - Francês)

tranylcypromine
tranylcypromine

maoi - tranylcypromine
tranylcypromine

tranylcypromine sulfate
sulfate de tranylcypromine

sulfate, tranylcypromine
sulfate de tranylcypromine

tranylcypromine (product)
tranylcypromine

tranylcypromine* and its salts
tranylcypromine (*) et ses sels

tranylcypromine sulfate (medication)
sulfate de tranylcypromine

tranylcypromine [chemical/ingredient]
tranylcypromine

tranylcypromine (inn) and its salts
tranylcypromine (dci) et ses sels

tranylcypromine also decreased prostaglandin formation.
la tranylcypromine a aussi diminué la formation de prostaglandines.

tranylcypromine sulfate [chemical/ingredient]
sulfate de tranylcypromine

inhibitors (e. g. phenelzine, tranylcypromine).
exemple, phénelzine, tranylcypromine).

tranylcypromine sulfate 10mg tablet 01919598 parnate gsk
phÉnelzine (sulfate de) 15mg comprimé 00476552 nardil pfi

cunninghamella echinulata, tranylcypromine, biotransformation, toxicity model.
cunninghamella echinulata, biotransformation, tranylcypromine, modèle de toxicité.

patients rated themselves as significantly improved relative to placebo only while receiving tranylcypromine.
les patients ont considérés par eux mêmes une amélioration significative relative au placebo en prenant de la tranylcypromine.

neither tranylcypromine nor pargyline in concentrations up to 0.1 mm had any effect on choline transport.
ni la tranylcypromine ni la pargyline, pour des concentrations atteignant 0.1 mm, n'ont d'effet sur le transport de la choline.

the monoamine oxidase inhibitors iproniazid, pargyline, tranylcypromine, and harmaline bad no apparent effect.
les inhibiteurs de la monoamine oxydase iproniazide, pargyline, tranylcypromine et harmaline n'entrainent aucune modification sensible.

at time t═o, an maoi was administered intraperitoneally (tranylcypromine, 20 mg/kg).
au temps t=0 on a administré un i m a o par voie intrapéritonéale (tranylcypromine 20 mg/kg).

the use as claimed in claim 9, wherein said substances which inhibit cyp2a6 are selected from methoxsalen, and tranylcypromine.
utilisation selon la revendication 9, dans laquelle on sélectionne lesdites substances qui inhibent le cyp2a6 parmi le méthoxsalène et la tranylcypromine.

examples of maois include nialamide, iproniazide, selegeline, moclobemide, phenelzine, tranylcypromine, isocarboxazid and toloxatone.
a titre d’ exemple, les imao incluent: le nialamide, l’ iproniazide, la sélégiline, le moclobémide, la phénelzine, la tranylcypromine, l’ isocarboxacide et la toloxatone.